Tranylcypromine hemisulfate is an irreversible, nonselective MAO inhibitor. Tranylcypromine is used as an antidepressant and anxiolytic agent in the clinical treatment of mood and anxiety disorders, respectively. Tranylcypromine (100 μM) significantly protects RGCs from glutamate neurotoxicity-induced apoptosis as well as apoptosis induced by oxidative stress. Tranylcypromine promotes mitogen-activated protein kinase 12 (p38 MAPKγ) expression under conditions of glutamate (Glu)-induced stress.
Tranylcypromine (500 mM) injection exerts neuroprotective effects within intracellular apoptotic signaling pathways and suppresses morphologic changes in the retina of the rat, suppresses caspase 3 activity and recovers p38 MAPKγ expression in the retina after NMDA-induced injury, and enhances RGC survival after retinal injury via the attenuation of NMDA neurotoxicity. Tranylcypromine (10 µg/g) causes an approximate and significant doubling of labeled cells in the combined brain regions examined, as detected by BrdU immunohistochemistry.
| Molecular Weight | 364.46 |
| Formula | C18H24N2O4S |
| CAS Number | 13492-01-8 |
| Solubility (25°C) | Water: ≥ 30 mg/mL (Need ultrasonic) |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
| Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
| Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
| Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
| Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
| Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
| Related Monoamine Oxidase Products |
|---|
| Indazole
Indazole, also called isoindazole, a heterocyclic aromatic organic compound. |
| PF9601N
PF9601N is a monoamine oxidase B (MAO-B) inhibitor with neuroprotective properties in various ex vivo and in vivo models of Parkinson's disease (PD) for the study of excitotoxicity-mediated neurodegenerative diseases. In addition, PF9601N is a click chemistry reagent containing an Alkyne moiety that undergoes a copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing an Azide moiety. |
| Verbasoside
Decaffeoylacteoside is an inhibitor of AChE/BChE/LOX with moderate activity. |
| ETAP
ETAP is a MAO-A and MAO-B inhibitor. |
| Rosmarinic acid racemate
Rosmarinic acid racemate is the racemate of Rosmarinic acid. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
